Change the DNA of Your Portfolio:
Growth Opportunities Through Genomics
Thanks to DNA sequencing and the genomic revolution, we could be on the cusp of a brand-new era of healthcare solutions that could extend and enhance the quality of human life. Several key biotech companies are pioneering scientific developments that can change everything we know about healthcare.
In this upcoming webcast, join ARK Invest and VettaFi for a deep-dive discussion on the companies driving change in targeted therapeutics, bioinformatics, CRISPR technology, and more.
Topics will include:
- Predictions for growth in biotech for the rest of 2022—and beyond.
- A close look at relevant biotech companies in the space, including Teladoc and Exact Sciences.
- How financial advisors can incorporate a biotech sleeve to enhance an investment portfolio.
Accepted for one hour of CFP/CIMA CE credit for live and on-demand attendees
CFA Institute members are encouraged to self-document their continuing professional development activities in their online CE tracker.
Nicholas GrousAssociate Portfolio Manager
Simon BarnettResearch Analyst
Todd RosenbluthHead of Research